-
Dr. Bing Xu and Dr. Zhijuan Lin’s Team: Highlighting the Role of the Immune Microenvironment and the Promise of Bispecific Antibodies for FL Patients
The 66th American Society of Hematology (ASH) Annual Meeting concluded successfully from December 7 to 10, 2024, in San Diego, USA. As the largest and most comprehensive international academic conference in the field of hematology, ASH attracts numerous experts and scholars worldwide to discuss groundbreaking research and advancements in hematology.At this year’s ASH meeting, the…
-
ASH 2024 | Dr. Fengkui Zhang: How to Treat Severe Aplastic Anemia in Patients Unable to Undergo Transplantation? Promising Results with a New TPO-RA Combined with IST
The 66th Annual Meeting of the American Society of Hematology (ASH) was held from December 7–10, 2024, in San Diego, USA. As the largest international academic conference in hematology, it showcased cutting-edge research and the latest advancements in drug development, representing the highest level of academic achievement in the field. Severe aplastic anemia (SAA) remains…
-
ASH 2024 | Dr. Xiaowen Tang’s Team Pioneers Innovative Transplant Pathways: From Enhanced Preconditioning Strategies to Multi-Targeted CAR-T Sequential Transplantation
The 66th Annual Meeting of the American Society of Hematology (ASH), held from December 7–10, 2024, in San Diego, USA, brought together global hematology experts to discuss the latest advancements in the field. Among the highlights of this year’s conference were seven groundbreaking studies from Dr. Xiaowen Tang’s team at The First Affiliated Hospital of…
-
ASH 2024 | Dr. Ying Wang: Sustained Remission and Safety – Promising Prospects of CD19 CAR-T Therapy for R/R B-ALL
The 66th Annual Meeting of the American Society of Hematology (ASH), held from December 7–10, 2024, in San Diego, USA, brought together global hematology experts to discuss the latest advancements in the field. Among the highlights was a poster presentation (P4196) by Dr. Ying Wang from the Institute of Hematology and Blood Diseases Hospital, Chinese…
-
Expert Interview with Dr. Jiajie Liao: Optimizing Cost-Effective Strategies for Hepatitis B Treatment
At the conference, Dr. Jiajie Liao from Zhongshan Hospital, led a research team that presented a study evaluating the impact of various antiviral treatment strategies on achieving functional cure for…
-
Expert Interview with Dr. Jun Li: New Insights into Hepatitis B-Related ACLF Research
Hepatology Digest: At this year’s AASLD conference, your team’s research on biomarkers for diagnosing HBV-related ACLF received the Poster of Distinction award. Could you elaborate on the main findings and…
-
ASH 2024丨Dr. Wen Gao: SPVD Quadruple Therapy Offers New Hope for NDMM Patients with Renal Impairment
Despite significant advancements in the treatment of multiple myeloma (MM) in recent years, particularly with the advent of innovative therapies, the prognosis for certain high-risk patient groups remains suboptimal. This is especially true for newly diagnosed multiple myeloma (NDMM) patients with renal impairment. At the 2024 American Society of Hematology (ASH) Annual Meeting held from…
-
CAHON 2024 Winter Symposium: A New Decade of Excellence Begins, Uniting Global Minds to Shape the Future of Hematology and Oncology
The 66th Annual Meeting of the American Society of Hematology (ASH), the largest and most comprehensive international conference in hematology, successfully took place from December 7 to 10, 2024, in San Diego, USA. This annual event attracts numerous hematology experts and scholars worldwide to exchange ideas and discuss significant breakthroughs in the field. During this…
Connecting Medical Expertise through Media